 |
|
Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia and Tardive Akathisia in Patients with Schizophrenia: Report of Three Cases
Yakup Albayrak, Kenji Hashimoto
Psychiatry Investig. 2013;10(4):417-420. Published online 2013 Oct 24 DOI: https://doi.org/10.4306/pi.2013.10.4.417
|
|
The effects of sigma-1 agonist fluvoxamine on experimental induced tardive dyskinesia model in rats
Esra Toplu Uslu, Murat Mengi, Elmas Beyazyüz, Aliye Çelikkol, Yakup Albayrak
Progress in Neuro-Psychopharmacology and Biological Psychiatry.2023; 126: 110787. CrossRef In vitroandin vivosigma 1 receptor imaging studies in different disease states
Hebaalla Agha, Christopher R. McCurdy
RSC Medicinal Chemistry.2021; 12(2): 154. CrossRef Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report
Domenico De Berardis, Federica Vellante, Michele Fornaro, Laura Orsolini, Alessandro Valchera, Gaia Baroni, Yong-Ku Kim, Giovanni Martinotti, Massimo Di Giannantonio
International Clinical Psychopharmacology.2020; 35(2): 113. CrossRef A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine
Yakup Albayrak, Murat Beyazyüz, Özlem Abbak, Ece Altındağ
Clinical Psychopharmacology and Neuroscience.2019; 17(1): 134. CrossRef Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia
Samaneh Ghotbi Ravandi, Mohammad Shabani, Hamideh Bashiri, Monavvar Saeedi Goraghani, Mehdi Khodamoradi, Masoumeh Nozari
Neuroscience Letters.2019; 706: 151. CrossRef Evaluation of the Effect of Fluvoxamine in Patients With Schizophrenia Under Risperidone Treatment
Alireza Haji Seyed Javadi, Ali Akbar Shafikhani, Seyed Mohsen Zamir, Zahra Farzane Khanshir
Journal of Clinical Psychopharmacology.2018; 38(2): 119. CrossRef The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review
Christoffer Polcwiartek, Jimmi Nielsen
Psychopharmacology.2016; 233(5): 741. CrossRef The pain of pain: Challenges of animal behavior models
James E. Barrett
European Journal of Pharmacology.2015; 753: 183. CrossRef Drug-induced Movement Disorders
Shyamal H. Mehta, John C. Morgan, Kapil D. Sethi
Neurologic Clinics.2015; 33(1): 153. CrossRef
|